alopecia, cancer chemotherapy, cancer combination chemotherapy, cancer patient, capecitabine, carbamazepine, cardiotoxicity, ciprofloxacin, cisplatin, clarithromycin, conference paper, dacarbazine, diarrhea, diclofenac, diet, disulfiram, doxorubicin, doxycycline, drug dose reduction, drug withdrawal, erythromycin, etoposide, fluorouracil, human, hypotension, imatinib, infection, ketoconazole, kidney disease, liver disease, miconazole, nausea, nausea and vomiting, nephrotoxicity, neuroendocrine tumor, oxaliplatin, patient information, phenobarbital, phenytoin, photosensitivity, practice guideline, pregnancy, priority journal, stomatitis, streptozocin, temozolomide, therapy effect
dx.doi.org/10.1159/000225950, hdl.handle.net/1765/17596
Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships
Erasmus MC: University Medical Center Rotterdam

Eriksson, B, Annibale, B, Bajetta, E, Mitry, E, Pavel, M, Platania, M, … Wiedenmann, B. (2009). ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Chemotherapy in patients with neuroendocrine tumors. In Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships (Vol. 90, pp. 214–219). doi:10.1159/000225950